- Home
- KYMR vs DBRG Comparison
KYMR vs DBRG Comparison
Compare KYMR & DBRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- DBRG
- Stock Information
- Founded
- KYMR 2015
- DBRG 1991
- Country
- KYMR United States
- DBRG United States
- Employees
- KYMR N/A
- DBRG N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- DBRG Real Estate Investment Trusts
- Sector
- KYMR Health Care
- DBRG Real Estate
- Exchange
- KYMR Nasdaq
- DBRG Nasdaq
- Market Cap
- KYMR 1.8B
- DBRG 1.9B
- IPO Year
- KYMR 2020
- DBRG 2009
- Fundamental
- Price
- KYMR $29.64
- DBRG $11.06
- Analyst Decision
- KYMR Buy
- DBRG Strong Buy
- Analyst Count
- KYMR 15
- DBRG 9
- Target Price
- KYMR $55.47
- DBRG $16.28
- AVG Volume (30 Days)
- KYMR 650.3K
- DBRG 3.5M
- Earning Date
- KYMR 05-09-2025
- DBRG 05-01-2025
- Dividend Yield
- KYMR N/A
- DBRG 0.36%
- EPS Growth
- KYMR N/A
- DBRG N/A
- EPS
- KYMR N/A
- DBRG 0.32
- Revenue
- KYMR $58,885,000.00
- DBRG $566,324,000.00
- Revenue This Year
- KYMR $32.80
- DBRG N/A
- Revenue Next Year
- KYMR $8.88
- DBRG $19.16
- P/E Ratio
- KYMR N/A
- DBRG $29.57
- Revenue Growth
- KYMR N/A
- DBRG N/A
- 52 Week Low
- KYMR $19.45
- DBRG $6.41
- 52 Week High
- KYMR $53.27
- DBRG $17.33
- Technical
- Relative Strength Index (RSI)
- KYMR 48.27
- DBRG 62.35
- Support Level
- KYMR $28.06
- DBRG $10.66
- Resistance Level
- KYMR $30.28
- DBRG $11.59
- Average True Range (ATR)
- KYMR 1.65
- DBRG 0.59
- MACD
- KYMR -0.19
- DBRG 0.03
- Stochastic Oscillator
- KYMR 27.96
- DBRG 65.20
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About DBRG DigitalBridge Group Inc.
DigitalBridge Group Inc is a developer of alternative asset manager dedicated to investing in digital infrastructure. The company's platform invests in and operates businesses across the digital ecosystem, including cell towers, data centres, fiber, small cells, and edge infrastructure, to provide clients with funds for digital infrastructure real estate infrastructure.